Literature DB >> 9292953

Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety.

B E Tendler1, K Shoukri, C Malchoff, D MacGillivray, R Duckrow, T Talmadge, G R Ramsby.   

Abstract

We describe two Caucasian women with the concurrence of Graves' disease and the moyamoya phenomenon (radiological evidence of collateral cerebral blood vessels like "puffs of smoke" due to cerebrovascular occlusive disease). One patient presented with acute cerebrovascular ischemia due to Moyamoya disease shortly after radioactive iodine therapy for Graves' disease and the second presented with Graves' disease 10 years after being diagnosed with moyamoya dysplastic cerebral vessels. The optimal treatment of hyperthyroidism in these patients is unknown; however, careful control of the hyperthyroidism by any modality seems reasonable. Our limited experience suggests that antithyroid drugs and radioactive iodine therapy are rational options. Thyroidectomy appears to be a safe therapeutic alternative, although long-term efficacy may be difficult to assure. Both of our patients had to be treated twice for hyperthyroidism. Whether Graves' disease and Moyamoya coexist because of an aggressive autoimmune mechanism is a concept that remains to be settled.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292953     DOI: 10.1089/thy.1997.7.625

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  14 in total

Review 1.  Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.

Authors:  Shigeo Ohba; Toru Nakagawa; Hideki Murakami
Journal:  Neurosurg Rev       Date:  2011-03-19       Impact factor: 3.042

Review 2.  Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndrome in association with Graves thyrotoxicosis.

Authors:  S W Hsu; J C Chaloupka; D Fattal
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

3.  Reversible MR angiographic findings in a patient with autoimmune Graves disease.

Authors:  Ufuk Utku; Talip Asil; Yahya Celik; Dilek Tucer
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

Review 4.  Pathophysiology and management of intracranial arterial stenosis around the circle of Willis associated with hyperthyroidism: case reports and literature review.

Authors:  Fumihiro Matano; Yasuo Murai; Koji Adachi; Takayuki Kitamura; Akira Teramoto
Journal:  Neurosurg Rev       Date:  2013-11-19       Impact factor: 3.042

5.  Fatal outcome in a Hispanic woman with moyamoya syndrome and Graves' disease.

Authors:  Julian Choi; Perin Suthakar; Farbod Farmand
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-11-04

Review 6.  A Recent Update of Clinical and Research Topics Concerning Adult Moyamoya Disease.

Authors:  Jin Pyeong Jeon; Jeong Eun Kim
Journal:  J Korean Neurosurg Soc       Date:  2016-10-24

7.  Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report.

Authors:  Shou-Chen Ren; Bao-Qin Gao; Wei-Li Yang; Wei-Xin Feng; Jian Xu; Shao-Wu Li; Yong-Jun Wang
Journal:  Exp Ther Med       Date:  2016-10-03       Impact factor: 2.447

Review 8.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.

Authors:  Takeshi Mikami; Hime Suzuki; Katsuya Komatsu; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-06       Impact factor: 1.742

Review 9.  A case of Moyamoya disease in a girl with thyrotoxicosis.

Authors:  Ran Lee; Kihye Sung; Yong Mean Park; Jeong Jin Yu; Young-Cho Koh; Sochung Chung
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

10.  A case of graves' disease diagnosed in the course of bilateral carotid artery stenoses (moyamoya disease); a case report and review of the literature.

Authors:  Hotaka Kamasaki; Takako Takeuchi; Takeshi Mikami; Katsuhide Komeichi; Hiroyuki Tsutsumi
Journal:  Clin Pediatr Endocrinol       Date:  2013-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.